Skip to main content

Femasys Inc. (FEMY) Stock Forecast

Data as of Sep 19, 2026

Healthcare · Current price $2.58 (+1.18%)

Consensus Target
Upside
Analysts
2
Rating
Buy(2.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

FEMY vs Sector & Market

MetricFEMYHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count2818
Target Upside+22217.1%+21.5%
P/E Ratio-0.793.7638.34

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$5M$5M$6M2
2027-12-31$14M$14M$14M3
2028-12-31$31M$33M$35M3
2029-12-31$64M$66M$71M2
2030-12-31$122M$126M$134M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.34$-0.31$-0.302
2027-12-31$-0.31$-0.29$-0.272
2028-12-31$-0.35$-0.16$0.093
2029-12-31$0.12$0.12$0.131
2030-12-31$0.72$0.76$0.821

Frequently Asked Questions

What is the analyst consensus for FEMY?

The consensus among 2 analysts covering Femasys Inc. (FEMY) is Buy with an average price target of N/A.

How many analysts cover FEMY?

2 analysts have issued ratings for Femasys Inc. in the past 12 months.

Is FEMY a buy or sell right now?

Based on 2 analyst ratings, FEMY has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.

What are the earnings estimates for FEMY?

Analysts estimate FEMY will report EPS of $-0.31 for the period ending 2026-12-31, with revenue estimated at $5M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.